George Soros Alnylam Pharmaceuticals, Inc. Transaction History

Soros Fund Management LLC

  • $4.68 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$70.9 - $87.82 $2.84 Million - $3.51 Million
-40,000 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$65.86 - $92.79 $2.63 Million - $3.71 Million
40,000 New
40,000 $2.9 Million
Q3 2017

Nov 14, 2017
SELL
$72.53 - $118.27 $507,710 - $827,890
-7,000 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
7,000
7,000 $558,000

Others Institutions Holding ALNY

# of Institutions
642
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.4B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track George Soros's Portfolio

Track George Soros Portfolio

Follow George Soros (Soros Fund Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soros Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soros Fund Management LLC and George Soros with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email